bronchodilators

New policies on the use of corticosteroids and bronchodilators-including Clenbuterol--for all yearlings, horses in and out of training and unraced 2-year-olds will be introduced at the beginning of the UK and Irish yearling sales from Sept. 1 forward, Tattersalls and Goffs announced on Monday. Starting with the Goffs UK Premier Yearling Sale, all stock sold at the two sales companies will have these restrictions applied. These new Conditions of Sale will allow buyers to have post-sale testing for corticosteroids and bronchodilators (Clenbuterol). Any positive test or any trace of bronchodilators...

Officials from Keeneland Association, Fasig-Tipton Company Inc. and Ocala Breeders' Sales Company Inc. have jointly announced significant changes to policies regarding medication, including restriction of non-steroidal anti-inflammatory drugs (NSAIDs) and a ban on bronchodilators at all 2-year-old sales, and limited use of riding crops at under-tack shows. The revised Conditions of Sale for each sales company take effect March 2020. These proactive measures demonstrate continued uniformity among the United States' three largest Thoroughbred auction houses and are the latest round of leadership reforms undertaken in recent years, following action in...